Government

The first two months of the Trump Administration have seen significant actions shaping the 2025 legislative and policy landscape, particularly for fiscal negotiations in science, education, and academic medicine. Policymakers must navigate differing priorities and perspectives, which complicates negotiations to ensure continued operation of the federal government. Due to this environment, the impact on biomedical... Read More

 You must be a member to access this page. Log in Become a Member If you believe you have a membership and are unable to log in contact membership@ashg.org Read More

Just a few days after winning the election, the incoming Trump Administration began to identify key health policy proposals. Some of these priorities include addressing mental health issues and tackling the opioid overdose crisis, accelerating translational research, and improving rural health. The National Institutes of Health (NIH) remains under scrutiny, with ongoing discussions surrounding its... Read More

For Immediate Release: August 5, 2024, 11:30 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424, press@ashg.org American Society of Human Genetics (ASHG) President Bruce D. Gelb, M.D., released the following statement in response to the U.S. Senate Appropriations Committee’s approval by a 25-3 vote of the fiscal year (FY) 2025 bill for the... Read More

In honor of Rare Disease Week, ASHG staff and over 500 rare disease advocates from across the U.S. took part in the EveryLife Foundation for Rare Disease’s 2024 Legislative Conference in Washington, DC, from February 25-28. During this multi-day event participants were educated on policy proposals impacting the rare disease community ahead of a visit... Read More